HEERLEN, Netherlands, Sept. 1, 2022 /PRNewswire/ -- Royal DSM, a global purpose-led science-based company, today announces the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil, which was first announced on 7 June 2022.
Prodap is an animal nutrition and technology company that combines technology offerings, consulting services, and customized nutritional solutions to drive efficiency and sustainability in animal farming. By harnessing the power of Prodap's digital solutions, DSM will take another step forward in its Precision & Personalization journey. DSM will strengthen and further develop its digital solutions to reach more markets globally, enabling smarter nutritional decision-making thanks to artificial intelligence and other tools. Prodap will complement DSM's deep animal nutrition knowledge and advisory capabilities with its extensive consultancy experience, facilitating an even higher level of customer experience. Additionally, by supporting more efficient farming, the acquisition contributes to DSM's commitment to enabling a double-digit reduction in on-farm livestock emissions by 2030 as part of its 2021 food system commitments.
DSM
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
Or find us on:
Facebook: http://www.facebook.com/DSMcompany
Twitter: http://www.twitter.com/DSM
LinkedIn: http://www.linkedin.com/company/3108
YouTube: http://www.youtube.com/user/dsmcompany
For more information DSM Media Relations ANH Mirelle van der Kreeft tel. +31 (0) 45 5782420 e-mail media.contacts@dsm.com |
DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 e-mail investor.relations@dsm.com |
DSM Media Relations LATAM Cristina Cassis Tel. +5511 991213941 e-mail cristina.cassis@dsm.com |
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg
